Douglas Noonan
Douglas Noonan
Verified email at uninsubria.it
TitleCited byYear
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
A Albini, G Pennesi, F Donatelli, R Cammarota, S De Flora, DM Noonan
Journal of the National Cancer Institute 102 (1), 14-25, 2010
6152010
The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, andá…
DM Noonan, A Fulle, P Valente, S Cai, E Horigan, M Sasaki, Y Yamada, ...
Journal of Biological Chemistry 266 (34), 22939-22947, 1991
4431991
The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells
A Albini, R Soldi, D Giunciuclio, E Giraudo, R Benelli, L Primo, D Noonan, ...
Nature medicine 2 (12), 1371, 1996
4341996
HIV-1 Tat protein mimicry of chemokines
A Albini, S Ferrini, R Benelli, S Sforzini, D Giunciuglio, MG Aluigi, ...
Proceedings of the National Academy of Sciences 95 (22), 13153-13158, 1998
3161998
Tumors and inflammatory infiltrates: friends or foes?
C Brigati, DM Noonan, A Albini, R Benelli
Clinical & experimental metastasis 19 (3), 247-258, 2002
3062002
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity
M Morini, M Mottolese, N Ferrari, F Ghiorzo, S Buglioni, R Mortarini, ...
International journal of cancer 87 (3), 336-342, 2000
3022000
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
DM Noonan, ADL Barbaro, N Vannini, L Mortara, A Albini
Cancer and Metastasis Reviews 27 (1), 31-40, 2008
2372008
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate
G Fassina, R Vene, M Morini, S Minghelli, R Benelli, DM Noonan, A Albini
Clinical Cancer Research 10 (14), 4865-4873, 2004
2292004
Cancer prevention by targeting angiogenesis
A Albini, F Tosetti, VW Li, DM Noonan, WW Li
Nature reviews Clinical oncology 9 (9), 498, 2012
2232012
Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation
R Benelli, M Morini, F Carrozzino, N Ferrari, S Minghelli, L Santi, ...
The FASEB Journal 16 (2), 267-269, 2002
2202002
Tumor inflammatory angiogenesis and its chemoprevention
A Albini, F Tosetti, R Benelli, DM Noonan
Cancer research 65 (23), 10637-10641, 2005
2122005
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A
P Scapini, M Morini, C Tecchio, S Minghelli, E Di Carlo, E Tanghetti, ...
The Journal of Immunology 172 (8), 5034-5040, 2004
2092004
Interaction of HIV-1 Tat Protein with Heparin ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE
M Rusnati, D Coltrini, P Oreste, G Zoppetti, A Albini, D Noonan, ...
Journal of Biological Chemistry 272 (17), 11313-11320, 1997
2091997
The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells
A Baldi, A De Luca, M Morini, T Battista, A Felsani, F Baldi, C Catricala, ...
Oncogene 21 (43), 6684, 2002
1972002
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-κB and Akt as targets
A Albini, R Dell’Eva, R VenÚ, N Ferrari, DR Buhler, DM Noonan, ...
The FASEB Journal 20 (3), 527-529, 2006
1902006
HIV-tat protein is a heparin-binding angiogenic growth factor.
A Albini, R Benelli, M Presta, M Rusnati, M Ziche, A Rubartelli, ...
Oncogene 12 (2), 289-297, 1996
1881996
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinaseá…
T Florio, M Morini, V Villa, S Arena, A Corsaro, S Thellung, MD Culler, ...
Endocrinology 144 (4), 1574-1584, 2003
1842003
Tissue inhibitors of metalloproteases: regulation and biological activities
G Fassina, N Ferrari, C Brigati, R Benelli, L Santi, DM Noonan, A Albini
Clinical & experimental metastasis 18 (2), 111-120, 2000
1722000
Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
A Albini, G Fontanini, L Masiello, C Tacchetti, D Bigini, P Luzzi, ...
AIDS (London, England) 8 (9), 1237-1244, 1994
1721994
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS
D Giunti, G Borsellino, R Benelli, M Marchese, E Capello, MT Valle, ...
Journal of leukocyte biology 73 (5), 584-590, 2003
1712003
The system can't perform the operation now. Try again later.
Articles 1–20